• Je něco špatně v tomto záznamu ?

Four seasons of Czech asthma study: asthma characteristics and management reality in the Czech Republic

M. Terl, P. Pohunek, M. Kuhn, J. Bystron

. 2020 ; 57 (8) : 898-910. [pub] 20190530

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, multicentrická studie, pozorovací studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21012315

Objective: To describe the characteristics and management of asthma in clinical practice in the Czech Republic in the context of international guidelines and clinical realities.Methods: Data were collected over four seasons from summer 2016 to spring 2017 and are mostly presented using descriptive statistics.Results: We obtained valid data for 4557 adult patients with asthma, including detailed phenotyping (71% eosinophilic allergic, 10% eosinophilic non-allergic, 19% non-eosinophilic non-allergic asthma) from 58 allergologists and 56 pulmonologists. The average time to diagnosis was 3 years. In more than half of the subjects, bronchodilator testing (BDT) results were available at primary diagnosis. More than 10% of physicians did not test for mold allergy. Occupational asthma was diagnosed in 0.7% of subjects. According to the attending physician, 68% of patients had well-controlled and 10% had uncontrolled asthma. Ninety-four percent of patients were on preventive treatment, with 91% using an inhaled corticosteroids (ICS) at an average dose of 705 µg/day budesonide equivalent. Approximately 75% of patients were on an ICS/LABA, with 91% using fixed combinations. Among patients using ICS/formoterol, a maintenance and reliever therapy regime was prescribed in 67%.Conclusions: The quality of asthma management in the Czech Republic is comparable to that of other developed countries and better in some respects (frequent BDT, phenotyping, and use of preventive treatment). Nevertheless, there is unnecessary delay in diagnosis and lack of research on possible environmental causes (workplace, molds). Pharmacotherapy shows good adherence to guidelines. Although 10% of patients show poor control, there is concurrently a trend for overtreatment.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21012315
003      
CZ-PrNML
005      
20210507104629.0
007      
ta
008      
210420s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1080/02770903.2019.1619082 $2 doi
035    __
$a (PubMed)31144543
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Terl, Milan $u Department of Pulmonary Medicine, Faculty of Medicine in Pilsen, University Hospital, Charles University, Prague, Czech Republic
245    10
$a Four seasons of Czech asthma study: asthma characteristics and management reality in the Czech Republic / $c M. Terl, P. Pohunek, M. Kuhn, J. Bystron
520    9_
$a Objective: To describe the characteristics and management of asthma in clinical practice in the Czech Republic in the context of international guidelines and clinical realities.Methods: Data were collected over four seasons from summer 2016 to spring 2017 and are mostly presented using descriptive statistics.Results: We obtained valid data for 4557 adult patients with asthma, including detailed phenotyping (71% eosinophilic allergic, 10% eosinophilic non-allergic, 19% non-eosinophilic non-allergic asthma) from 58 allergologists and 56 pulmonologists. The average time to diagnosis was 3 years. In more than half of the subjects, bronchodilator testing (BDT) results were available at primary diagnosis. More than 10% of physicians did not test for mold allergy. Occupational asthma was diagnosed in 0.7% of subjects. According to the attending physician, 68% of patients had well-controlled and 10% had uncontrolled asthma. Ninety-four percent of patients were on preventive treatment, with 91% using an inhaled corticosteroids (ICS) at an average dose of 705 µg/day budesonide equivalent. Approximately 75% of patients were on an ICS/LABA, with 91% using fixed combinations. Among patients using ICS/formoterol, a maintenance and reliever therapy regime was prescribed in 67%.Conclusions: The quality of asthma management in the Czech Republic is comparable to that of other developed countries and better in some respects (frequent BDT, phenotyping, and use of preventive treatment). Nevertheless, there is unnecessary delay in diagnosis and lack of research on possible environmental causes (workplace, molds). Pharmacotherapy shows good adherence to guidelines. Although 10% of patients show poor control, there is concurrently a trend for overtreatment.
650    _2
$a aplikace inhalační $7 D000280
650    _2
$a agonisté beta-2-adrenergních receptorů $x aplikace a dávkování $7 D058666
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a alergologie a imunologie $x normy $x statistika a číselné údaje $x trendy $7 D000486
650    _2
$a antiastmatika $x aplikace a dávkování $7 D018927
650    _2
$a bronchiální astma $x diagnóza $x farmakoterapie $7 D001249
650    _2
$a budesonid $x aplikace a dávkování $7 D019819
650    _2
$a průřezové studie $7 D003430
650    _2
$a opožděná diagnóza $x statistika a číselné údaje $7 D057210
650    _2
$a fixní kombinace léků $7 D004338
650    _2
$a lékové předpisy $x statistika a číselné údaje $7 D011307
650    _2
$a kombinovaná farmakoterapie $x metody $x statistika a číselné údaje $7 D004359
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a formoterol fumarát $7 D000068759
650    _2
$a glukokortikoidy $x aplikace a dávkování $7 D005938
650    _2
$a dodržování směrnic $x statistika a číselné údaje $x trendy $7 D019983
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a směrnice pro lékařskou praxi jako téma $7 D017410
650    _2
$a pneumologie $x normy $x statistika a číselné údaje $x trendy $7 D015272
650    _2
$a společnosti lékařské $x normy $7 D012955
650    _2
$a mladý dospělý $7 D055815
651    _2
$a Česká republika $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a pozorovací studie $7 D064888
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Pohunek, Petr $u Department of Paediatrics, Motol University Hospital, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Kuhn, Matyas $u Data Analysis Department, Institute of Biostatistics and Analysis, Brno, Czech Republic
700    1_
$a Bystron, Jaromir $u Department of Allergology and Clinical Immunology, University Hospital Olomouc, Olomouc, Czech Republic
773    0_
$w MED00002534 $t The Journal of asthma : official journal of the Association for the Care of Asthma $x 1532-4303 $g Roč. 57, č. 8 (2020), s. 898-910
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31144543 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210507104627 $b ABA008
999    __
$a ok $b bmc $g 1650644 $s 1132694
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 57 $c 8 $d 898-910 $e 20190530 $i 1532-4303 $m The Journal of asthma $n J Asthma $x MED00002534
LZP    __
$a Pubmed-20210420

Najít záznam

Citační ukazatele

Možnosti archivace